The Sidney Kimmel Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancer
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2019-04-12
- Target Recruit Count
- 77
- Registration Number
- NCT00348595
- Locations
- 🇺🇸
The Harry and Jeanette Weinberg Building, Baltimore, Maryland, United States
Cyclophosphamide and Rituximab Followed By Vaccine Therapy in Treating Patients With Chronic Lymphocytic Leukemia
- Conditions
- Leukemia
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer
- First Posted Date
- 2006-06-08
- Last Posted Date
- 2019-04-03
- Target Recruit Count
- 50
- Registration Number
- NCT00334542
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
🇺🇸Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States
Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABC
- Conditions
- Carcinoma, DuctalBreast NeoplasmsAdenocarcinoma
- Interventions
- Device: Active Breathing Coordinator
- First Posted Date
- 2006-05-03
- Last Posted Date
- 2025-02-28
- Target Recruit Count
- 57
- Registration Number
- NCT00321048
- Locations
- 🇺🇸
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
ChemoRT With Adjuvant Chemo in Pancreatic Cancer (TARCEVA)
- First Posted Date
- 2006-04-12
- Last Posted Date
- 2020-06-04
- Target Recruit Count
- 48
- Registration Number
- NCT00313560
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2006-04-06
- Last Posted Date
- 2019-02-22
- Target Recruit Count
- 32
- Registration Number
- NCT00311623
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
🇺🇸University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
🇺🇸Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- Interventions
- First Posted Date
- 2006-03-22
- Last Posted Date
- 2020-02-19
- Target Recruit Count
- 60
- Registration Number
- NCT00305760
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase Gene
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2006-03-17
- Last Posted Date
- 2010-03-19
- Target Recruit Count
- 65
- Registration Number
- NCT00303927
- Locations
- 🇪🇸
Hospital Universitario 12 de Octubre, Madrid, Spain
🇺🇸Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders
- Conditions
- Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic/Myeloproliferative Diseases
- First Posted Date
- 2006-02-17
- Last Posted Date
- 2010-05-06
- Target Recruit Count
- 70
- Registration Number
- NCT00293410
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
- Conditions
- Lung Cancer
- First Posted Date
- 2006-02-17
- Last Posted Date
- 2013-05-06
- Target Recruit Count
- 42
- Registration Number
- NCT00293280
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States